Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

AdvaMed International Survey Results Will Help Determine Policy Agenda

This article was originally published in The Gray Sheet

Executive Summary

AdvaMed plans to hold a breakout session at its international conference in September specifically to examine the needs of small manufacturers looking to tap into the international market

You may also be interested in...



International News In Brief

Marjory Searing: AdvaMed names former Clinton administration trade advisor VP-global strategy & analysis. Currently senior-VP at Civic Service, Inc., a Japan-focused consulting firm, Searing begins Dec. 2 at AdvaMed, where she succeeds Ed Rozynski (1"The Gray Sheet" April 19, 2002, In Brief). With 27 years of experience at the Treasury Department and Department of Commerce, including a post as deputy assistant secretary for Asia, Searing has worked on the market-oriented, sector-selective (MOSS) agreements to improve market access for medical products in Japan...

Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer

Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025.  It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.

Xaira Launches With $1bn-Plus And End-To-End AI Strategy

ARCH and Foresite incubated the company and recruited Genentech R&D veteran Marc Tessier-Lavigne to keep data generation, machine learning research and drug development under one roof.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT018102

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel